English
Syncom Formulations India Ltd Q3 Results
- BSE: 524470
- NSE: SYNCOMF
- ISIN: INE312C01025
- Sector: Biotechnology & Drugs
BSE
12.94
-0.10 (-0.77%)
-0.10 (-0.77%)Volume1.27 L
Updated: Wed 14 Jan, 2026 | 15:27:14
NSE
13.00-0.02 (-0.15%)
-0.02 (-0.15%)Volume7.16 L
Updated: Wed 14 Jan, 2026 | 15:40:27
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 24
Note: Comparison is on QoQ basis
Quarterly - Syncom Formulations India Ltd Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 24 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 114.11 | 91.45 | 24.77% | 59.25 | 92.58% |
| Depreciation/ Amortization | 1.31 | 1.30 | 0.58% | 1.45 | -9.57% |
| Operating Income | 13.43 | 10.86 | 23.61% | 5.89 | 128.04% |
| Net Income | 13.00 | 11.11 | 17.05% | 7.00 | 85.70% |
| Other Operating Expenses Total | 12.20 | 11.95 | 2.10% | 8.52 | 43.23% |
| Net Income Before Taxes | 17.26 | 14.85 | 16.24% | 9.36 | 84.40% |
| Total Revenue | 127.53 | 102.31 | 24.65% | 65.14 | 95.78% |
| Selling/ General/ Admin Expenses Total | 13.95 | 12.40 | 12.44% | 9.74 | 43.25% |
| Diluted Normalized EPS | 0.14 | 0.16 | -12.50% | 0.09 | 55.16% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.